MISTIE INTRACEREBRAL HEMORRHAGE TRIAL

Does faster clot removal give better patient outcomes in ICH?

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form
Steve Mayo

Steve Mayo

President of Emissary International (www.Emissary.com) the CRO supporting CLEAR and MISTIE programs. Steve is known in the CRO industry as "SuperMonitor" due to an article he wrote many years ago about life as a clinical research associate.

Steve enjoys photography, travelling to far-away places, hiking with his son, and web design. He maintains several websites: http://www.Troop-201.com and http://OmniVesting.com
712

We've added a new feature to our website to help with maintaining your training documents. After login, you will now see a new item in the study menu labeled MY QUIZ RESULTS. Click that and you will be taken to a listing of all quizzes you have taken. There you can review your results as well as download another copy of your training course certificate.  You will only be able to see your own documents and you must first login. If you are a coordinator needing to obtain a certificate from another site team member, you can still ask us to download it for you. This should make it easier to keep track of which courses you have taken.

476

We are delighted to report that the first patient has now enrolled in the MISTIE III intracerebral hemorrhage trial! In the race to be the first out-of-the-gate, the honor goes to Hartford Hospital.

Dr. Inam Kureshi and his team at Hartford enrolled patient #1 at 17:02 on 30-Dec-2013, marking the official start of the study period. Congratulations go out to the Hartford team which includes the coordinator, Sara Jasak, RN, and the neurointensivist, Dr. Robert Brown. This was the 12th patient to be screened at this site since the site was activated on 11-December. We are especially proud of how Sara Jasak has entered the clinical data in near real-time; just a few days into the acute treatment and we already have 54 final case form pages with no open queries! Way to go, Sara!

Continue reading
1708

The U.S. launch of MISTIE-III is fast approaching and U.S. sites should be preparing now for the November investigator's meeting (Europe & Asia will launch next year). For the new folks, here's a quick run-down on the several websites you may need to visit. Click the links to go directly to them.

Continue reading
500

Karin Jonczak at Abington Memorial Hospital made a wonderful suggestion to compile the post-discharge outcome assessment visit worksheets into packets. Nichol McBee kindly compiled these sets, one for Day-30, Day-90, Day-180, Day-270, and Day-365 as a zipped set of PDF forms that you can place on your desktop for quick printing.

Each set (or packet) has the Day-8 IVC removal form since the date for removal of the IVC is unspecified.  The same consideration goes for Adverse Events, Conditions/Procedures, Death, Withdrawal of Care, Resource Utilization and Final Status forms.

You can download the zip file below or from the QUICK DOWNLOADS link in the side panel.

Name File size    
clear3-follow-up-visit-packets 1.05 MB

1490

You've submitted your Site Suitability Assessment Survey (SASS), completed the team feasibility interview, and have been accepted into the MISTIE-III consortium. Congratulations! Now what are the next steps? Your "Startup Sherpa" (a/k/a your site manager) will guide you on this next step "up the mountain" but here's a brief summary of the steps and some important links.

You must book your hotel room no later than 18-October, so be sure to read all the details below!

Continue reading

Brain Injury Outcomes

Johns Hopkins University
1550 Orleans Street
CRB-II, 3M50 South
Baltimore, MD 21231 USA
Office:   (410) 614-6996
Fax: (410) 502-7869
 
24-Hr: (410) 736-1368